Qualifying Therapeutic Discovery Project Grants for the State of Oklahoma
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
| Applicant Name | Project Name | Grants Awarded for 2009 | Grants Awarded for 2010 |
|---|---|---|---|
| Altheus Therapeutics, Inc | ALTH12: Novel combination treatment for inflammatory bowel disease | $ 244,479.24 | |
| Charlesson, LLC | Nanotechnology-based Formulations for Efficient and Long-Term Ophthalmic Drug Delivery | $ 244,479.24 | |
| Charlesson, LLC | Development of a novel Stat3 inhibitor for the treatment of Diabetic Retinopathy and AMD | $ 75,048.69 | $ 169,430.55 |
| Charlesson, LLC | Preclinical development of CLT-003 for the treatment of Diabetic Macular Edema | $ 216,861.53 | $ 27,617.71 |
| COARE BIOTECHNOLOGY | COARE PROJECT | $ 244,479.25 | |
| DormaTarg, Inc. | Development of Small Molecule Therapeutics to Target Micrometastatic Cancer Cells | $ 84,821.78 | $ 88,222.34 |
| Immuno-Mycologics Inc (IMMY) | High Impact Point-of-Care Cyptococcosis diagnostic test | $ 77,995.52 | $ 85,538.45 |
| Midwest Medical Isotopes LLC | Identifying early Recurrence of Braintumor using 18-Fluorothymidine | $ 244,479.25 | |
| Midwest Medical Isotopes LLC | Staging and Monitoring Therapy in Patients with Prostate Cancer with 18 Fluorothymidine | $ 244,479.25 | |
| NanoBioMagnetics Inc | MNP technology for the delivery of chemotherapeutics | $ 33,960.15 | $ 140,000.00 |
| NanoMed Targeting Systems Inc. | Magnetic Targeting of Therapeutics for Atrial Fibrillation | $ 244,479.24 | |
| OMEDtech LLC | Diagnostic Test of Low Protein Levels For Early Detection and Prevention of Preterm Birth | $ 30,208.00 | |
| Selexys Pharmaceuticals Corporation | A Humanized Anti-P-selectin Antibody to Treat Sickle Cell Disease | $ 244,479.24 | |
| Siwa Biotech Corporation | Development of TPST Inhibitors as Non_Hormonal Male Contraceptives | $ 122,089.50 | $ 122,389.75 |
References/Related Topics
Page Last Reviewed or Updated: 2012-10-12
